Publications by authors named "Barbara Buttin"

Claim this Profile
Q
Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel.
Dana M Chase, Jørn Herrstedt, Eirwen M Miller, Lucy Gilbert, Oleksandr Zub, Barbara Buttin

Int J Gynecol Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532].
Alessandro D Santin, Virginia Filiaci, Stefania Bellone, Roisin O'Cearbhaill, Elena S Ratner, Barbara M Buttin

Gynecol Oncol Rep· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008).
Alessandro D Santin, Virginia Filiaci, Stefania Bellone, Elena S Ratner, Cara A Mathews, Barbara M Buttin

Gynecol Oncol Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
Abigail D Winder, Kruti P Maniar, Jian-Jun Wei, Dachao Liu, Denise M Scholtens, Barbara M Buttin

Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease.
Anna Strohl, Kristina Mori, Stacey Akers, Wiam Bshara, Barbara Buttin

J Ovarian Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma.
Brian D McMillen, Margarita M Aponte, Zhaojian Liu, Irene B Helenowski, Denise M Scholtens, Barbara M Buttin

Mod Pathol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of robotics on practice management of endometrial cancer: transitioning from traditional surgery.
Anna V Hoekstra, Arati Jairam-Thodla, Alfred Rademaker, Diljeet K Singh, Barbara M Buttin

Int J Med Robot· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robotic surgery in gynecologic oncology: impact on fellowship training.
Anna V Hoekstra, Jacqueline M Morgan, John R Lurain, Barbara M Buttin, Diljeet K Singh

Gynecol Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synuclein-gamma (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma.
Jacqueline Morgan, Anna V Hoekstra, Eloise Chapman-Davis, Jennifer L Hardt, J Julie Kim, Barbara M Buttin

Gynecol Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
Emily Berry, Kellie S Matthews, Diljeet K Singh, Barbara M Buttin, John R Lurain

Gynecol Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of robot-assisted and traditional radical hysterectomy for early-stage cervical cancer.
M Patrick Lowe, Anna V Hoekstra, Arati Jairam-Thodla, Diljeet K Singh, Barbara M Buttin

J Robot Surg· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide-induced reversible interstitial pneumonitis in a patient with recurrent ovarian cancer.
Barbara M Buttin, Michael J Moore

Gynecol Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancer.
Akila N Viswanathan, Barbara M Buttin, Anne M Kennedy

Radiographics· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.
Erin C Ward, Anna V Hoekstra, Leen J Blok, P Hanifi-Moghaddam, John R Lurain, Barbara M Buttin

Endocrinology· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.
Anna V Hoekstra, Erin C Ward, Jennifer L Hardt, John R Lurain, Diljeet K Singh, Barbara M Buttin

Gynecol Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates.
David Gius, Margo C Funk, Eric Y Chuang, Sheng Feng, Phyllis C Huettner, Barbara M Buttin

Cancer Res· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource utilization for ovarian cancer patients at the end of life: how much is too much?
Sharyn N Lewin, Barbara M Buttin, Matthew A Powell, Randall K Gibb, Janet S Rader

Gynecol Oncol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of referral guidelines for women with pelvic masses.
Samuel S Im, Alan N Gordon, Barbara M Buttin, Charles A Leath, Bobbie S Gostout

Obstet Gynecol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history.
Barbara M Buttin, Matthew A Powell, David G Mutch, Sheri A Babb, Phyllis C Huettner

Am J Hum Genet· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation.
Barbara M Buttin, Matthew A Powell, David G Mutch, Janet S Rader, Thomas J Herzog

Clin Cancer Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.
Paul J Goodfellow, Barbara M Buttin, Thomas J Herzog, Janet S Rader, Randall K Gibb

Proc Natl Acad Sci U S A· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelial ovarian tumors of low malignant potential: the role of microinvasion.
Barbara M Buttin, Thomas J Herzog, Matthew A Powell, Janet S Rader, David G Mutch

Obstet Gynecol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis